PIOGLITAZONE HYDROCHLORIDE

NDC 65862-512 · Aurobindo Pharma Limited

Generic namepioglitazone hydrochloride

Dosage formTABLET

RouteORAL

Active ingredient(s)PIOGLITAZONE HYDROCHLORIDE

Strength15 mg/1

Pharmacologic classPeroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA], Peroxisome Proliferator-activated Receptor gamma Agonists [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]

Marketing categoryANDA

Packages

65862-512-05 — 500 TABLET in 1 BOTTLE (65862-512-05)

65862-512-10 — 3 BLISTER PACK in 1 CARTON (65862-512-10) / 10 TABLET in 1 BLISTER PACK

65862-512-30 — 30 TABLET in 1 BOTTLE (65862-512-30)

65862-512-90 — 90 TABLET in 1 BOTTLE (65862-512-90)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

64764-123 — alogliptin and pioglitazone, 64764-151 — pioglitazone, 64764-158 — pioglitazone and metformin hydrochloride, 64764-251 — alogliptin and pioglitazone, 64764-253 — alogliptin and pioglitazone, 64764-254 — alogliptin and pioglitazone, 64764-301 — pioglitazone, 64764-302 — pioglitazone and glimepiride, 64764-304 — pioglitazone and glimepiride, 64764-451 — pioglitazone, 65862-513 — pioglitazone hydrochloride, 65862-514 — pioglitazone hydrochloride, 65862-525 — Pioglitazone Hydrochloride and Metformin Hydrochloride, 65862-526 — Pioglitazone Hydrochloride and Metformin Hydrochloride, 66993-821 — pioglitazone and glimepiride, 66993-822 — pioglitazone and glimepiride, 68071-2264 — Pioglitazone, 68071-2373 — Pioglitazone, 68071-4964 — Pioglitazone, 68071-5199 — Pioglitazone, +68 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.